CD34 and acute myeloid leukemia: In contrast to what is observed in the patient at relapse, cytarabine resistant cells generated in an AML xenograft mouse model are not enriched for the CD34+CD38− phenotype or for cells containing enhanced functional leukemia-initiating potential, neither were these cells enriched for stem cell genes [8].